Party drug tested as potential relief for debilitating long COVID symptoms
NCT ID NCT06821087
Summary
This small pilot study is testing whether ketamine, a medication used for anesthesia and depression, can help ease the fatigue and thinking problems (often called 'brain fog') experienced by people with Long COVID. Twenty adults with Long COVID will receive four ketamine injections over two weeks. Researchers will measure changes in symptoms, quality of life, and brain function to see if the treatment is helpful and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UT Health Austin
Austin, Texas, 78712, United States
Conditions
Explore the condition pages connected to this study.